vimarsana.com

Latest Breaking News On - Aduhelm aducanumab - Page 1 : vimarsana.com

Alzheimer s Research Breakthroughs Give Cause for Optimism

Advances in Alzheimer’s research raise hopes of preventing and someday curing the senior plague.

United statesKathleen mangiPercy griffinMonica morenoKristinaf zdanysYazeeds maghaydahLeqembi lecanemabAduhelm aducanumabRexulti brexpiprazoleEricm reimanJames mangiDrug administrationBanner alzheimer instituteUconn healthUs department of energyAlzheimer association

Why Shares of Anavex Life Sciences Rose 12 4% in February

The company's first-quarter earnings report detailed positive news regarding its pipeline.

Christopher misslingAduhelm aducanumabDrug administrationAnavex life sciencesDisease assessment scale cognitiveExcellence phase

As US launch falters, Biogen ditches Aduhelm application in Europe

Biogen’s aducanumab, already hamstrung in the U.S. by a stifling coverage decision, won’t be hitting the European market anytime soon.

Aduhelm aducanumabEuropean unionEuropean medicines agencyAlzheimer 039s diseaseAntibody drugsFierce pharma homepage

Biogen s troubled Aduhelm hit with CMS slapdown—now what?

The Centers for Medicare & Medicaid Services (CMS) has

Aduhelm aducanumabMichel vounatsosDrug reimbursementAlzheimer 039s diseaseCenters for medicare amp medicaid services cmsFierce pharma homepage

3 more deaths among patients on Biogen s Aduhelm fuel safety concerns, though no link established: analyst

The death of three additional Alzheimer’s disease patients using Biogen’s Aduhelm has heaped more concern on the safety of the controversial treatment, though it is too early to determine how the patients died.

Brian abrahamsInformation actAduhelm aducanumabS fdaAlzheimer 039 sDrug safety

vimarsana © 2020. All Rights Reserved.